Ventas, Inc. filings document the regulatory record of a healthcare real estate investment trust whose common stock trades on the New York Stock Exchange under VTR. The company’s disclosures include Form 8-K reports for operating results, quarterly and annual earnings releases, dividend-related events, material financing agreements and capital markets activity.
Recent filings also cover amendments to credit facilities, registered senior notes issued by Ventas Realty, Limited Partnership and guaranteed by Ventas, ATM sales agreement updates, officer-transition disclosures and proxy materials addressing director elections, executive compensation, shareholder voting matters and governance.
Ventas, Inc. director Roxanne M. Martino acquired 18 common-stock units on October 6, 2026, under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees, pursuant to her deferral election. The units are payable solely in common stock and subject to the election and Plan terms. She reported 67,446 shares held directly after the transaction; $81.86 was the issuer's closing price per share on the grant date.
Ventas, Inc. (VTR) reports that Laurida Sayed, SVP, Chief Accounting Officer, acquired 4,301 restricted stock units on October 5, 2026, under the 2022 Incentive Plan. The grant-date closing price for Ventas common stock was $81.36 per share. Sayed's reported direct common-stock holdings after the transaction were 4,307 shares.
Ventas, Inc. (VTR) reported that Sayed Laurida, its SVP, Chief Accounting Officer, directly held 6 shares of common stock. The holding entry is dated October 5, 2026.
Ventas, Inc. director Maurice S. Smith acquired 478 common stock units on October 1, 2026, in a grant under the Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees. The units are payable solely in common stock and subject to the director's deferral election and the plan's terms. The $83.73 per-share figure is the common stock closing price on the grant date. Smith's direct holdings following the grant were 31,789 shares.
Sumit Roy, a director of Ventas, Inc. (VTR), was granted 373 shares on October 1, 2026, under the Non-Employee Directors’ Cash Compensation Deferral Plan in lieu of director fees. The units are payable solely in common stock. The grant-date closing price was $83.73 per share, and Roy’s reported direct holdings afterward were 25,245 shares.
Ventas, Inc. director Roxanne M. Martino received a grant of 582 common-stock units on October 1, 2026, under the Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees pursuant to her deferral election. The units are payable solely in common stock and are subject to the deferral election and Plan terms. Her reported direct position following the grant was 67,428 shares. The stated $83.73 per share was the closing price on the grant date.
Ventas, Inc. director Matthew J. Lustig received 447.868 common-stock units on October 1, 2026, under the Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees, pursuant to his deferral election. The units are payable solely in common stock and subject to the election and Plan terms. The reported grant-date closing price was $83.73 per share; his reported direct holdings after the grant were 96,183 shares.
Ventas, Inc. (VTR) appointed Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, effective on or around October 5, 2026. On that date, Executive Vice President and Chief Financial Officer Robert F. Probst will cease serving as interim Chief Accounting Officer but will remain Chief Financial Officer.
Sayed will receive an annual base salary of $500,000, a target annual bonus opportunity of 60% of base salary, and eligibility to participate in Ventas’s long-term incentive plan, with her 2026 bonus and long-term incentives prorated for 2026 service. To offset compensation forfeited at her current employer, she will receive a one-time cash sign-on bonus of $150,000 and a one-time grant of restricted stock units with a grant date fair value of $350,000, vesting ratably over three years. She has signed the company’s standard Employee Protection and Noncompetition Agreement.
Ventas, Inc., an institutional investment manager, filed a Form 13F holdings report indicating it is reporting all of its discretionary equity holdings itself. The summary shows 1 reportable holding with an aggregate reported value of $91,930,210, based on the manager’s Form 13F information table.
Wattula Andy reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. executive Andy Wattula reported two equity compensation grants of common-stock-settled restricted stock units on August 1, 2026. One award covers 10,694 units vesting in 2027, 2028 and 2029; the other covers 4,314 units vesting in three annual installments, all under the 2022 Incentive Plan at a reference price of $93.51 per share.